Combined Bcl-2/mTOR inhibition was observed to lead to enhanced radiosensitivity via induction of apoptosis and autophagy in vitro and in a lung cancer xenograft model; this is a potential therapeutic strategy for enhancing radiation therapy in patients with non-small cell lung cancer. Here, MTOR is linked to lung cancer.